Lupin Opens 100,000 Sq. Ft. Expansion at NJ Manufacturing Facility, Creates New Jobs

URLhttps://www.pharmpro.com/news/2017/05/lupin-opens-
Sourcepharmpro.com
Date Published05/10/2017
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Lupin Limited
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):50
What product(s) and/or service(s) were outsourced domestically?Manufacturing
Year reshoring announced:2016
Year reshoring implemented or to be implemented:2018
Offshore, work was done:In-house
Domestically, the work will be done:In-house
Capital investment ($):880
Country(ies) from which reshored:India
City reshored to:Somerset
State(s) reshored to:NJ
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredPharmaceuticals
What domestic positive factors made reshoring more attractive?Infrastructure (transport, internet, power), Manufacturing/engineering joint innovation (R&D)
Find Reshoring Articles